LifeNexus introduces personal health card
BROOMFIELD, Colo. LifeNexus recently introduced its personal health card, a dual-purpose payment/loyalty card that comes equipped with an embedded microprocessor, the iChip, designed for an individually controlled health platform.
The personal health card can be used to maintain personal health records by securely transferring accurate information at the time and point of need. This will allow professionals access to a patient’s personal health record through card-based consumer authorization, which is both encrypted and password-protected.
The card is EMV-compliant and can be used at the retail pharmacy point of sale for medical/prescription data along with loyalty and/or payment features, LifeNexus noted.
The personal health record also can be directly linked to an unlimited number of disparate databases.
“This platform could offer a retailer a very unique healthcare platform, while enhancing loyalty and potentially prescription adherence,” the company stated. “Pharmacy is quickly becoming the front door to health care, and … an all-encompassing card program like the LifeNexus personal health card can help enhance the retailer’s efforts to be that ‘gateway’ to good health care.”
NACDS, NCPA in joint statement praise CMS’ move to withdraw provisions of AMP rule currently blocked by injunction
ALEXANDRIA, Va. National Association of Chain Drug Stores president and CEO Steve Anderson and National Community Pharmacists Association acting EVP and CEO Douglas Hoey issued a statement praising the proposed rule by the Centers for Medicare and Medicaid Services that would withdraw existing provisions of the Medicaid pharmacy reimbursement formula under the average manufacturer price model.
"We are pleased that the Centers for Medicare and Medicaid Services has proposed a rule that would withdraw provisions of what is known as the Medicaid average manufacturer price rule. The proposed rule calls for the withdrawal of existing provisions that define AMP, that determine the calculation of federal upper limits, and that define ‘multiple source drug.’ Put simply, all of these provisions relate to the reimbursement to pharmacies for generic Medicaid prescriptions, and thus impact patients’ access to pharmacies. The move to withdraw these provisions is a victory for patient care as it is delivered in America’s pharmacies every day."
"When we filed the lawsuit in 2007 we knew that patient care was at stake. It is important to point out that the withdrawal of these provisions is another step toward reducing what would have been major cuts to pharmacy reimbursement. The end result is not an increase in reimbursement to pharmacy, but rather the lessening of cuts that previously would have involved pharmacies selling most generic drugs at a loss, thereby threatening their long-term ability to provide patient care."
“We insisted that this policy was not appropriate. Separately, we also have urged that policy-makers should recognize the ability of pharmacies and pharmacists to help improve health and reduce healthcare costs. We are gratified that this sense is reflected in the pharmacy provisions of the new healthcare-reform law. The new law contains provisions ranging from dramatically reducing the AMP cuts to advancing medication therapy management, through which pharmacists can help patients take their medications correctly. … The costs related to poor medication adherence have been estimated to reach $290 billion annually, or 13% of all healthcare expenditures. We urged that patient care should not be jeopardized, but rather that pharmacy be engaged more strategically for the good of patient health and healthcare delivery."
“We anticipate issuing formal comments on CMS’ proposed rule to withdraw these provisions of the AMP rule, and we will continue to work with Congress and with CMS to advocate for access to pharmacy services for patients.”
Extract found in cinnamon may curb diabetes, heart disease
BELTSVILLE, Md. A water-soluble extract of cinnamon, which contains antioxidative compounds, could help reduce risk factors associated with diabetes and heart disease, according to a new study led by a Department of Agriculture chemist.
The study, led by chemist Richard Anderson and coauthored by Tim Ziegenfuss of the Center for Applied Health Sciences, examined 22 obese participants with prediabetes. The participants were divided into two groups, one receiving 250 mg of a dried water-soluble cinnamon extract and the other placebo, both twice daily along with their usual diets. Anderson found that the water-soluble cinnamon extract improved a number of antioxidant variables by as much as 13% to 23%, and improvement in antioxidant status was correlated with decreases in fasting glucose, he said.
Anderson also noted that additional research can tell whether the investigational study supported the idea that people who are overweight or obese could reduce oxidative stress and blood glucose by consuming cinnamon extracts.
The study was published in the Journal of the American College of Nutrition.